Javascript must be enabled to continue!
Abstract LB104: Detecting protein cleavage events in living cells using IMPRINTS-CETSA data
View through CrossRef
Abstract
The cell machinery is composed of a range of intricate and complex network of different regulatory pathways. Functionalities and interactions of this network are depending on proteins which are regulated by interactions, but also different posttranslational modifications (PTM) such as phosphorylation and proteolysis. Proteolysis is an irreversible posttranslational modification that hydrolyzes a peptide bond in a peptide or protein substrate thanks to several families of specialized proteases (Barrett et al. 2013). Proteolysis or proteolytic cleavage is a key step in different degradation processes as in the proteasome or during apoptosis but also for cell cycle regulation (Fatima, Fazili and Bhat 2022). Hence, identifying and understanding proteolytic events in the cell is essential to explain the cell machinery.
Recently in (Ramos et al. 2024) we established that we could detect such proteolytic events in intact cells by using the Cellular Thermal Shift Assay (CETSA) (Martinez Molina et al. 2013). More precisely, by using a specific format of CETSA coupled with mass spectrometry, IMPRINTS-CETSA (Integrated Modulation of Protein Interaction States -CETSA) reported by our lab in (Dai et al. 2018). IMPRINTS-CETSA has been used to address complex biological questions such as the study of sensitiveness and resistance of cancer cell lines (Liang et al. 2022) or uncover new insights in main biological events such as the cell cycle (Dai et al. 2018) or apoptosis (Ramos et al. 2024).
Following our work in (Ramos et al. 2024), we present a new and robust algorithm to detect and follow proteolytic events in living cells by analyzing IMPRINTS-CETSA data. Not only are we able to follow caspase cleavage cascades, but also cleavage from other proteases occurring in the cell such as cathepsins, meprins or granzymes. Moreover, by filtering the candidates obtained by our algorithm, we can also differentiate protein cleavage from PTMs and/or alternative splicing forms by using databases such as Uniprot and PhosphoSitePlus. Together this approach gives an unprecedented stringency in following proteolysis in the cell, e.g. during cancer drug action. To support this, we applied our newly developed method on the data from (Ramos et al. 2024) and (Dai et al. 2018). Additionally, to increase the coverage of potential cleavage sites, we’ve leveraged on increased data acquisition rate of Orbitrap Astral mass-spectrometer for enhanced IMPRINTS-CETSA time course profiling after apoptosis induction by the BCL2 inhibitor venetoclax drug in acute myeloblastic leukemia cells.
Citation Format:
Marc-Antoine Gerault Nicolas Gerault, Anderson Daniel Ramos, Sara Lööf, Alexey Chernobrovkin, Pär Nordlund. Detecting protein cleavage events in living cells using IMPRINTS-CETSA data [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 2 (Late-Breaking, Clinical Trial, and Invited Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_2):Abstract nr LB104.
American Association for Cancer Research (AACR)
Title: Abstract LB104: Detecting protein cleavage events in living cells using IMPRINTS-CETSA data
Description:
Abstract
The cell machinery is composed of a range of intricate and complex network of different regulatory pathways.
Functionalities and interactions of this network are depending on proteins which are regulated by interactions, but also different posttranslational modifications (PTM) such as phosphorylation and proteolysis.
Proteolysis is an irreversible posttranslational modification that hydrolyzes a peptide bond in a peptide or protein substrate thanks to several families of specialized proteases (Barrett et al.
2013).
Proteolysis or proteolytic cleavage is a key step in different degradation processes as in the proteasome or during apoptosis but also for cell cycle regulation (Fatima, Fazili and Bhat 2022).
Hence, identifying and understanding proteolytic events in the cell is essential to explain the cell machinery.
Recently in (Ramos et al.
2024) we established that we could detect such proteolytic events in intact cells by using the Cellular Thermal Shift Assay (CETSA) (Martinez Molina et al.
2013).
More precisely, by using a specific format of CETSA coupled with mass spectrometry, IMPRINTS-CETSA (Integrated Modulation of Protein Interaction States -CETSA) reported by our lab in (Dai et al.
2018).
IMPRINTS-CETSA has been used to address complex biological questions such as the study of sensitiveness and resistance of cancer cell lines (Liang et al.
2022) or uncover new insights in main biological events such as the cell cycle (Dai et al.
2018) or apoptosis (Ramos et al.
2024).
Following our work in (Ramos et al.
2024), we present a new and robust algorithm to detect and follow proteolytic events in living cells by analyzing IMPRINTS-CETSA data.
Not only are we able to follow caspase cleavage cascades, but also cleavage from other proteases occurring in the cell such as cathepsins, meprins or granzymes.
Moreover, by filtering the candidates obtained by our algorithm, we can also differentiate protein cleavage from PTMs and/or alternative splicing forms by using databases such as Uniprot and PhosphoSitePlus.
Together this approach gives an unprecedented stringency in following proteolysis in the cell, e.
g.
during cancer drug action.
To support this, we applied our newly developed method on the data from (Ramos et al.
2024) and (Dai et al.
2018).
Additionally, to increase the coverage of potential cleavage sites, we’ve leveraged on increased data acquisition rate of Orbitrap Astral mass-spectrometer for enhanced IMPRINTS-CETSA time course profiling after apoptosis induction by the BCL2 inhibitor venetoclax drug in acute myeloblastic leukemia cells.
Citation Format:
Marc-Antoine Gerault Nicolas Gerault, Anderson Daniel Ramos, Sara Lööf, Alexey Chernobrovkin, Pär Nordlund.
Detecting protein cleavage events in living cells using IMPRINTS-CETSA data [abstract].
In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 2 (Late-Breaking, Clinical Trial, and Invited Abstracts); 2025 Apr 25-30; Chicago, IL.
Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_2):Abstract nr LB104.
Related Results
Current Advances in CETSA
Current Advances in CETSA
Knowing that the drug candidate binds to its intended target is a vital part of drug discovery. Thus, several labeled and label-free methods have been developed to study target eng...
Endothelial Protein C Receptor
Endothelial Protein C Receptor
IntroductionThe protein C anticoagulant pathway plays a critical role in the negative regulation of the blood clotting response. The pathway is triggered by thrombin, which allows ...
Hijacking the ubiquitin and autophagy system for the development of chemical degraders
Hijacking the ubiquitin and autophagy system for the development of chemical degraders
Targeted protein degradation (TPD) marks an emerging novel technology within the chemical biology and drug discovery communities. The classical drug discovery process has focused o...
Successful transfection of Lymphoblastoid cell line (Preprint)
Successful transfection of Lymphoblastoid cell line (Preprint)
BACKGROUND
Immortalization is the stage that the cell goes through before full transformation [1]. Human resting B lymphocytes from peripheral blood are eas...
Recent Advances in Photoinduced Oxidative Cleavage of Alkenes
Recent Advances in Photoinduced Oxidative Cleavage of Alkenes
AbstractOxidative cleavage of alkenes leading to valuable carbonyl derivatives is a fundamental transformation in synthetic chemistry. In particular, ozonolysis is the mainstream m...
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
Human tissues comprise trillions of cells that populate a complex space of molecular phenotypes and functions and that vary in abundance by 4–9 orders of magnitude. Relying solely ...
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract
Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...
The cell and stress-specific canonical and non-canonical tRNA cleavage
The cell and stress-specific canonical and non-canonical tRNA cleavage
Abstract
Following stress, tRNA is cleaved to generate tRNA halves (tiRNAs). These stress-induced small RNAs have been shown to regulate translat...

